Precision Cellular Storage Ltd. 05359946 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is storage of stem cells Digita Accounts Production Advanced 6.30.9574.0 true false true 05359946 2024-01-01 2024-12-31 05359946 2024-12-31 05359946 core:CurrentFinancialInstruments 2024-12-31 05359946 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 05359946 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 05359946 bus:SmallEntities 2024-01-01 2024-12-31 05359946 bus:Audited 2024-01-01 2024-12-31 05359946 bus:FilletedAccounts 2024-01-01 2024-12-31 05359946 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05359946 bus:RegisteredOffice 2024-01-01 2024-12-31 05359946 bus:Director1 2024-01-01 2024-12-31 05359946 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05359946 1 2024-01-01 2024-12-31 05359946 countries:EnglandWales 2024-01-01 2024-12-31 05359946 2023-01-01 2023-12-31 05359946 2023-12-31 05359946 core:CurrentFinancialInstruments 2023-12-31 05359946 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 05359946 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 05359946

Precision Cellular Storage Ltd.

Filleted Financial Statements

for the Year Ended 31 December 2024

 

Precision Cellular Storage Ltd.

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 4

 

Precision Cellular Storage Ltd.

(Registration number: 05359946)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

95,899

106,179

Creditors: Amounts falling due within one year

5

(168,194)

(112,120)

Total assets less current liabilities

 

(72,295)

(5,941)

Creditors: Amounts falling due after more than one year

5

(25,774)

(32,537)

Net liabilities

 

(98,069)

(38,478)

Capital and reserves

 

Called up share capital

10,000

10,000

Other reserves

2,763,615

2,763,615

Retained earnings

(2,871,684)

(2,812,093)

Shareholders' deficit

 

(98,069)

(38,478)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 September 2025 and signed on its behalf by:
 

.........................................
Dr Danny Ramadan
Director

 

Precision Cellular Storage Ltd.

Notes to the Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
24 Brest Road
Derriford
Plymouth
PL6 5XP

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The company incurred a net loss in the period of £59,591 (2023: £57,086) and has net liabilities at the balance sheet date of £98,069.

The financial statements have been prepared on a going concern basis which the directors consider to be appropriate due to the immediate parent undertaking having pledged its financial support to the company for a period of at least 12 months from the date of approval of these financial statements.

The company has entered into a long-term agreement with a private human tissue bank to satisfy its obligations for the storage of stem cells. As per note 7, the company's financial commitment in this respect is £519,000 (2023: £549,000). As the company is providing storage only to historic customers, it is reliant on its immediate parent undertaking to continue to meet its financial obligations under this contract as well as covering other operating expenditure.

The financial position of the immediate parent undertaking to provide this support represents a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern and, therefore, to continue realising its assets and discharging its liabilities in the normal course of business. The financial statements do not include any adjustments that would result from the basis of preparation being inappropriate.

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 30 September 2025 was Dean Blunden BFP FCA, who signed for and on behalf of UHY Ross Brooke.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

 

Precision Cellular Storage Ltd.

Notes to the Financial Statements for the Year Ended 31 December 2024

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Debtors

2024
£

2023
£

Other debtors

95,899

106,179

95,899

106,179

Details of non-current trade and other debtors

£85,618 (2023 -£95,898) of other debtors is classified as non current.

 

Precision Cellular Storage Ltd.

Notes to the Financial Statements for the Year Ended 31 December 2024

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Trade creditors

 

14,400

12,658

Amounts owed to related parties

7

138,768

86,081

Other creditors

 

15,026

13,381

 

168,194

112,120

Creditors: amounts falling due after more than one year

2024
£

2023
£

Due after one year

Deferred income

25,774

32,537

6

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £519,000 (2023 - £549,000). The financial commitments are related to the storage of stem cells by a private human tissue bank.

7

Related party transactions

On the basis that 100% of the company's voting rights are controlled within the group, the company has taken advantage of the exemption under FRS 102 not to disclose intra-group transactions.

8

Parent and ultimate parent undertaking

The company's immediate parent is Precision Cellular Storage QSTP LLC, incorporated in Qatar.

 The ultimate parent is The Qatar Foundation, incorporated in Qatar.

 The ultimate controlling party is The Qatar Foundation.

Both companies' registered office address is Innovation Center, Qatar Science & Technology Park, Al Luqta Str., Al Rayyan, Doha, State of Qatar.